Here are relevant reports on : space-medicine-market
-
Aerospace Antimicrobial Coating Market by Platform (Aviation and Space), Application (Aviation (Cabin Seats, Sanitary Facilities) and Space (Air Purification)), Fit (OEM and Aftermarket), Material (Silver, Copper), and Region - Global Forecast to 2022
The aerospace antimicrobial coating market is projected to grow from an estimated USD 22.4 Million in 2017 to USD 31.2 Million by 2022, at a CAGR of 6.90% during the forecast period. This growth can be attributed to the increasing aircraft orders due to the rise in passenger traffic across the globe. In addition, airlines are more concerned about passenger safety and are investing in recoating of existing fleets of aircraft. The major players in this market are PPG (US), BASF (Germany), Sherwin Williams (US), Mankiewicz (Germany), AkzoNobel (Netherlands), Henkel (Germany), Hentzen (US), MAPAERO (France), Permagard (France), Dunmore (US), Hexion (US), and Polymer Technologies (US), among others.
- Published: January 2018
- Price: $ 4950
- TOC Available:
-
Future of Space Market : Emerging Technologies, Evolving Disruptions, Future Outlook and Growth Opportunities to 2064
The total space economy is expected to grow from USD 1.7 Trillion by 2034 to USD 6.1 Trillion by 2064
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
Weightless or White Space M2M Communication Standard Based Devices Market (2013-2018), By Standard, Application & Geography
Weightless is a M2M wireless communication standard managed by the Weightless SIG, or Special Interest Group. The standard is aimed for exchange of data between a base station and thousands of machines around it (using wavelength radio transmissions in unoccupied TV transmission channels) with high levels of security. The standard makes use of the empty fragments of spectrum interspaced between frequencies in use for terrestrial television broadcast band.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
European Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)), Application (Oncology, Thyroid, Cardiology), Procedures - Forecasts to 2020
Over the years, the European nuclear medicine/radiopharmaceuticals market has witnessed various advancements in radiopharmaceuticals. The European radiopharmaceuticals market is witnessing growth owing to an increasing number of radioisotope approvals for different clinical indications. Tc-99m and F-18 radioisotopes are estimated to contribute the highest to the European nuclear medicine diagnostic market in 2015, whereas Ra-223, I-131 and Y-90 ensured their leading position in the therapeutic market. The European nuclear medicine/radiopharmaceuticals market is expected to reach $1.62 Billion by 2020 from $1.09 Billion in 2015, growing at a CAGR of 8.2% from 2015 to 2020.
- Published: November 2015
- Price: $ 4950
- TOC Available:
-
Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) – Forecast to 2017
The market is broadly classified into two segments, namely, diagnostic and therapeutic; the former dominated with about 80.7% share in 2012. Radioisotopes in the diagnostic market are categorized as SPECT and PET. Technetium 99m (Tc-99m) dominated the SPECT radioisotope market in 2012, followed by thallium–201(Tl-201), gallium–67 (Ga-67), and iodine-123 (I-123). SPECT is majorly used in cardiology-related diagnosis; it is poised to grow at a CAGR of 10.2% from 2012 to 2017. The radiopharmaceuticals market in the Asia-Pacific region was valued at $500.8 million in 2012; it is poised to reach $824.9million in 2017 at a CAGR of 10.5%.
- Published: May 2013
- Price: $ 4950
- TOC Available:
-
Mice Model Market by Model Type (Inbred, Outbred, Hybrid), Service (Breeding, Rederivation), Application (Personalized Medicine), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology), End User (CROs) - Global Forecast to 2030
The global mice model market, valued at US$1.53 billion in 2024, stood at US$1.70 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from 2025 to 2030, culminating in a forecasted valuation of US$2.74 billion by the end of the period. The growth of this market is driven by several factors, such as rising adoption of mice models in preclinical studies due to genetic & physiological versatility; the increasing demand for mouse clinical trials; the rising demand for personalized medicine in oncology; and advancements in genetic engineering.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Latin American Bioinformatics Market by Sector (Agriculture, Molecular Medicine, Research & Animal), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Forecasts to 2017
The Latin American bioinformatics market was valued at $242 million in 2012 and is poised to reach $627 million by 2017, at a CAGR of 22%. The Latin American bioinformatics market displays lucrative growth potential. It is propelled by the rising number of training and development programs on usage of bioinformatics tools, which leads to an increase in the use of bioinformatics tools by industrial and academic bioinformaticians in life sciences research. In addition, the market is further driven by the high concentration of bioinformatics research institutes in Latin America that aim to facilitate the use of bioinformatics in life sciences research. However, the dearth of skilled personnel and facilities to ensure the proper use of bioinformatics products and services and the dearth of advanced and innovative bioinformatics tools and algorithms are limiting the growth of the bioinformatics market in Latin America.
- Published: March 2014
- Price: $ 4950
- TOC Available:
-
Sports Medicine Market by Product [Repair (Fracture & Ligament), Reconstruction, Implant, Prosthetic, Arthroscopy , Physiotherapy , Orthobiologics, Brace), Application (Knee, Shoulder, Ankle, Hip, Spine), End-User - Global Forecast to 2029
The global sports medicine market, valued at US$6.41 billion in 2023, stood at US$6.79 billion in 2024 and is projected to advance at a resilient CAGR of 6.8% from 2024 to 2029, culminating in a forecasted valuation of US$9.45 billion by the end of the period. Major drivers include increased cases of sports injury, the rise in participation in sports events, increased expenditure on research and development, and increased funding and research activities.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Nuclear Medicine Market by Type (Diagnostic (SPECT-Technetium, PET-F-18), Therapeutic (Beta Emitters-Y-90, Alpha Emitters, Brachytherapy), Application (Neurology, Thyroid, Oncology), Procedures, End User - Global Forecast to 2028
The global nuclear medicine market, valued at US$4.9 billion in 2021, stood at US$5.5 billion in 2023 and is projected to advance at a resilient CAGR of 11.3% from 2023 to 2028, culminating in a forecasted valuation of US$9.4 billion by the end of the period. The market growth in this sector is driven by factors such as advancements in radioisotope production technology and the rising prevalence of cancer and cardiovascular diseases (CVD).
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
Transradial Access Market by Product (Catheters, Guidewires, Sheath and Sheath Introducers), Application (Administration of Medicine and Administration of fluids), End User (Hospitals, Clinics & Ambulatory Centres) - Global Forecast 2022
The transradial access devices market is projected to reach USD 2.18 Billion by 2022 from USD 1.52 Billion in 2017, at a CAGR of 7.5%. The prominent players include Becton, Dickinson and Company (US) and Terumo Corporation (Japan), Teleflex Incorporated (US), Smiths Group Plc (UK), Edward Lifesciences Corporation (US), Medtronic (Ireland), Merit Medical System, Inc. (US), Boston Scientific (US), NIPRO Medical Corporation (US), AngioDynamics (US), Ameco Medical Industries (Egypt), and OSCOR Inc. (US).
- Published: March 2018
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
